Last updated on February 2018

Study to Assess the Safety Pharmacokinetics and Pharmacodynamics of Multiple Doses of COR-001

Brief description of study

This is a randomized, double-blind, placebo-controlled trial designed to evaluate the safety, pharmacokinetics, and pharmacodynamic effects of multiple doses of COR-001 or placebo

Clinical Study Identifier: NCT02868229

Contact Investigators or Research Sites near you

Start Over

Rahul Kakkar, M.D.

Nephrology Associates - Southeast Renal Research Institute
Chattanooga, TN United States
  Connect »